Lantheus Completes Merger with Progenics
WEBJun 22, 2020 · Progenics is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find, fight and follow cancer, including: therapeutic agents designed to treat cancer (AZEDRA ®, 1095, and PSMA TTC); prostate-specific membrane antigen ("PSMA") targeted imaging agents for prostate ...
Lantheus to Acquire Progenics to Form a Leading Precision …
WEBOct 2, 2019 · Progenics is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find, fight and follow cancer. Progenics takes a leading role in developing diagnostics that help guide physicians and therapeutics that treat patients.
Lantheus - Diagnostic and Therapeutic Innovations
WEBFrom precision diagnostics to radiopharmaceuticals—we pioneer next-generation solutions that help improve outcomes and lives. It’s our purpose. Our passion. Making a difference in the lives of patients.
Progenics Pharmaceuticals, Inc. - LinkedIn
WEBProgenics Pharmaceuticals, Inc. | 6,661 followers on LinkedIn. Progenics is now a Lantheus company. Follow us at https://www.linkedin.com/company/lantheus-medical-imaging/.
Progenics Pharmaceuticals Company Profile 2024: Valuation, …
WEBProgenics Pharmaceuticals Inc is an oncology company focused on developing and commercializing targeted medicines and artificial intelligence to treat cancer. Its portfolio includes AZEDRA (to treat malignant and recurrent pheochromocytoma and paraganglioma); 1404 and PyL (imaging agents for prostate cancer); 1404 …
FDA approves Progenics' treatment for rare adrenal gland tumors
WEBJul 30, 2018 · The U.S. Food and Drug Administration (FDA) on Monday approved Progenics Pharmaceuticals Inc's treatment for two types of rare adrenal gland tumors, making it the first drug approved in the...
Lantheus to buy Progenics to chase both cancer imaging diagnostics and ...
WEBOct 2, 2019 · Lantheus, makers of diagnostic imaging hardware and nuclear medicine agents, has moved to acquire cancer drugmaker Progenics Pharmaceuticals in an all-stock transaction.
Lantheus and Progenics Agree to Amended Transaction Terms
WEBOct 1, 2019 · Progenics is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find, fight and follow cancer, including: therapeutic agents designed to treat cancer (AZEDRA®, 1095, and PSMA TTC); prostate-specific membrane antigen (“PSMA”) targeted imaging agents for ...
Progenics Laboratories Pvt Ltd
WEBWelcome to Progenics, a leading genetics laboratory specializing in cutting-edge genetic testing, including next-generation sequencing (NGS) based assays. At Progenics, we are dedicated to the forefront of precision medicine, harnessing state-of-the-art high-throughput machinery to provide accurate and actionable insights.
Lantheus Completes Merger with Progenics - Business Wire
WEBJun 22, 2020 · Progenics is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find, fight and follow cancer, including ...
Skip to content